Lauren E, Shumba K, Fox M, MacLeod W, Stevens W, Mlisana K
PLOS Glob Public Health. 2024; 4(9):e0002127.
PMID: 39236028
PMC: 11376578.
DOI: 10.1371/journal.pgph.0002127.
Filippone P, Serrano S, Gwadz M, Cleland C, Freeman R, Linnemayr S
Front Public Health. 2023; 11:1167104.
PMID: 37234760
PMC: 10205984.
DOI: 10.3389/fpubh.2023.1167104.
Donenberg G, Atujuna M, Merrill K, Emerson E, Ndwayana S, Blachman-Demner D
BMC Public Health. 2021; 21(1):1708.
PMID: 34544403
PMC: 8454166.
DOI: 10.1186/s12889-021-11727-3.
Moodley N, Gray G, Bertram M
Clin Res HIV AIDS. 2017; 3(1).
PMID: 28824960
PMC: 5562157.
Medlock J, Pandey A, Parpia A, Tang A, Skrip L, Galvani A
Proc Natl Acad Sci U S A. 2017; 114(15):4017-4022.
PMID: 28320938
PMC: 5393239.
DOI: 10.1073/pnas.1620788114.
Epidemiology of HIV/AIDS in the East Azerbaijan Province, Northwest of Iran.
Haghgoo S, Joula H, Mohammadzadeh R, Sabour S, Yousefi R, Ghahramani G
Jundishapur J Microbiol. 2015; 8(8):e19766.
PMID: 26468361
PMC: 4601292.
DOI: 10.5812/jjm.19766v2.
Engineering a segmented dual-reservoir polyurethane intravaginal ring for simultaneous prevention of HIV transmission and unwanted pregnancy.
Clark J, Clark M, Shelke N, Johnson T, Smith E, Andreasen A
PLoS One. 2014; 9(3):e88509.
PMID: 24599325
PMC: 3943718.
DOI: 10.1371/journal.pone.0088509.
The association between poor antiretroviral adherence and unsafe sex: differences by gender and sexual orientation and implications for scale-up of treatment as prevention.
Remien R, Dolezal C, Wagner G, Goggin K, Wilson I, Gross R
AIDS Behav. 2013; 18(8):1541-7.
PMID: 24213215
PMC: 4016192.
DOI: 10.1007/s10461-013-0656-0.
Randomized comparison of universal and targeted HIV screening in the emergency department.
Lyons M, Lindsell C, Ruffner A, Wayne D, Hart K, Sperling M
J Acquir Immune Defic Syndr. 2013; 64(3):315-23.
PMID: 23846569
PMC: 4241750.
DOI: 10.1097/QAI.0b013e3182a21611.
Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.
Long E, Stavert R
J Gen Intern Med. 2013; 28(10):1294-301.
PMID: 23588668
PMC: 3785647.
DOI: 10.1007/s11606-013-2417-1.
Progress realized: trends in HIV-1 viral load and CD4 cell count in a tertiary-care center from 1999 through 2011.
Gale H, Rodriguez M, Hoffman H, Benator D, Gordin F, Labriola A
PLoS One. 2013; 8(2):e56845.
PMID: 23437255
PMC: 3577700.
DOI: 10.1371/journal.pone.0056845.
Characteristics and outcomes of initial virologic suppressors during analytic treatment interruption in a therapeutic HIV-1 gag vaccine trial.
Li J, Brumme C, Lederman M, Brumme Z, Wang H, Spritzler J
PLoS One. 2012; 7(3):e34134.
PMID: 22479542
PMC: 3316607.
DOI: 10.1371/journal.pone.0034134.
Experience in international clinical research: the HIV Prevention Trials Network.
Deshmane Sista N, Abdool Karim Q, Hinson K, Donnell D, Eshleman S, Vermund S
Clin Investig (Lond). 2012; 1(12):1609-1618.
PMID: 22348195
PMC: 3281583.
DOI: 10.4155/cli.11.156.
Right sizing funding for Alzheimer's disease.
Golde T, Lamb B, Galasko D
Alzheimers Res Ther. 2011; 3(3):17.
PMID: 21554753
PMC: 3226306.
DOI: 10.1186/alzrt76.
Solution structure of the monovalent lectin microvirin in complex with Man(alpha)(1-2)Man provides a basis for anti-HIV activity with low toxicity.
Shahzad-Ul-Hussan S, Gustchina E, Ghirlando R, Clore G, Bewley C
J Biol Chem. 2011; 286(23):20788-96.
PMID: 21471192
PMC: 3121468.
DOI: 10.1074/jbc.M111.232678.
